The two new HIV drugs, Emtriva and Reyataz

August 2003

The two new HIV drugs, Emtriva and Reyataz, will help simplify regimens...they're each given just ONCE a day.

Emtriva (emtricitabine) is a nucleoside analogue...similar to lamivudine (Epivir). It's well-tolerated and doesn't affect cytochrome P450 enzymes, so drug interactions aren't likely.

Emtriva is mostly excreted renally. Patients take it less often if they have a creatinine clearance < 50 mL/min.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote